Edesa Biotech Средняя величина рекомендации
Что обозначает Средняя величина рекомендации в Edesa Biotech?
Средняя величина рекомендации Edesa Biotech, Inc. является 2.00
Какое определение для Средняя величина рекомендации?
Средняя величина рекомендации является средним значением рейтингов аналитиков от 1,0 (активно покупать) до 5,0 (активно продавать).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Средняя величина рекомендации компаний в Health Care сектор на NASDAQ по сравнению с Edesa Biotech
Что делает Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Компании с средняя величина рекомендации похож на Edesa Biotech
- Cabot Oil & Gas имеет Средняя величина рекомендации из 1.96
- Truist имеет Средняя величина рекомендации из 1.96
- Delta Air Lines имеет Средняя величина рекомендации из 1.96
- Discover Services имеет Средняя величина рекомендации из 1.96
- United Micro Electronics имеет Средняя величина рекомендации из 1.96
- Tapestry Inc имеет Средняя величина рекомендации из 1.97
- Edesa Biotech имеет Средняя величина рекомендации из 2.00
- Trip.com Ltd имеет Средняя величина рекомендации из 2.03
- Sherwin-Williams Co имеет Средняя величина рекомендации из 2.03
- Canadian Pacific Kansas City имеет Средняя величина рекомендации из 2.03
- Arista Networks Inc имеет Средняя величина рекомендации из 2.03
- Anheuser-Busch InBev SA/NV имеет Средняя величина рекомендации из 2.03
- Celanese Corp имеет Средняя величина рекомендации из 2.04